BRIEF-Avenue Therapeutics Reports Q1 Loss Per Share Of $1.03

May 3 (Reuters) - Avenue Therapeutics Inc:

* AVENUE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

* Q1 LOSS PER SHARE $1.03

* AS OF MARCH 31, 2018, CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $15.0 MILLION Source text for Eikon: Further company coverage: